|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Development Revenue | |||||
| Grant | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Development Revenue | |||||
| Grant | |||||
| Total cost of revenue | |||||
| Gross loss | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income, net | |||||
| Net loss | |||||
| Net loss per share – basic and diluted (in dollars per share) | |||||
| Weighted average number of shares outstanding – basic and diluted (in shares) | |||||
Loading...